Security Snapshot

AtriCure, Inc. - Common Stock (ATRC) Institutional Ownership

CUSIP: 04963C209

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

220

Shares (Excl. Options)

50,013,349

Price

$28.53

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+826,328
Value change
-$2,230,294
Number of holders
220
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
49,743,456
SEC-reported price per share
$26.69
Insider filing price
$26.69
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ATRC - AtriCure, Inc. - Common Stock is tracked under CUSIP 04963C209.
  • 220 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 234 to 220 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,928,695,662 to $1,462,601,752.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 220 institutions filings for Q1 2026.

Open SEC evidence

Security key

04963C209

Latest holder period

Q1 2026

13F holders

220

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
ATRC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $136,165,391 3,862,837 BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 6.8% -15% $96,504,294 -$16,738,950 3,382,555 -15% Wellington Management Group LLP 31 Mar 2026
Hood River Capital Management LLC 6.2% +3.8% $122,501,931 +$6,839,133 3,096,611 +5.9% Hood River Capital Management LLC 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% $78,305,863 2,744,685 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $72,265,491 2,532,965 Vanguard Capital Management 31 Mar 2026
MACQUARIE GROUP LTD 4.6% -9.2% $80,700,257 -$7,537,719 2,289,369 -8.5% Macquarie Group Limited 30 Sep 2025
Champlain Investment Partners, LLC 4.4% -22% $71,407,964 -$21,803,353 2,137,963 -23% Champlain Investment Partners, LLC 31 Mar 2025

As of 31 Mar 2026, 220 institutional investors reported holding 50,013,349 shares of AtriCure, Inc. - Common Stock (ATRC). This represents 101% of the company’s total 49,743,456 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
76%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.1% 4,042,681 -0.57% 0% $115,337,702
WELLINGTON MANAGEMENT GROUP LLP 6.8% 3,382,555 -14% 0.02% $96,504,294
ALLIANCEBERNSTEIN L.P. 6.6% 3,258,872 -8.6% 0.04% $128,920,976
Hood River Capital Management LLC 6.3% 3,117,545 +0.68% 0.89% $88,943,559
VANGUARD PORTFOLIO MANAGEMENT LLC 5.4% 2,702,632 0% 0% $77,106,091
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,155,764 0% 0% $61,503,947
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 3.6% 1,804,927 -11% 0.09% $51,495,000
GOLDMAN SACHS GROUP INC 3.4% 1,667,166 +88% 0.01% $47,564,245
MARSHALL WACE, LLP 3% 1,467,524 +61% 0.04% $41,868,462
STATE STREET CORP 2.6% 1,302,162 +4.8% 0% $37,150,682
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,226,116 +2.9% 0% $34,988,106
Divisadero Street Capital Management, LP 2.3% 1,159,955 1.5% $33,093,516
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 2.1% 1,060,806 +11% 0.04% $30,264,796
NEUBERGER BERMAN GROUP LLC 2.1% 1,050,282 -3.3% 0.02% $29,954,828
DIMENSIONAL FUND ADVISORS LP 2% 997,759 +8.2% 0.01% $28,465,965
Champlain Investment Partners, LLC 2% 971,111 -17% 0.35% $27,705,797
GW&K Investment Management, LLC 1.9% 963,415 +1.2% 0.24% $27,486,000
KENNEDY CAPITAL MANAGEMENT LLC 1.7% 834,155 -0.38% 0.5% $23,798,442
BANK OF AMERICA CORP /DE/ 1.5% 768,561 +14% 0% $21,927,046
TWO SIGMA INVESTMENTS, LP 1.5% 751,003 +97% 0.02% $21,426,116
First Light Asset Management, LLC 1.5% 729,521 -38% 1.9% $20,813,234
VOYA INVESTMENT MANAGEMENT LLC 1.4% 719,649 +1% 0.02% $20,531,586
MORGAN STANLEY 1.4% 719,162 +108% 0% $20,517,698
DAFNA Capital Management LLC 1.2% 597,431 0% 3.9% $17,044,706
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.2% 585,353 +15% 0.01% $16,700,121

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 50,013,349 $1,462,601,752 -$2,230,294 $28.53 220
2025 Q4 48,743,756 $1,928,695,662 -$52,107,022 $39.56 234
2025 Q3 48,137,442 $1,696,572,476 -$26,346,560 $35.25 219
2025 Q2 48,899,026 $1,601,933,467 -$39,427,096 $32.77 197
2025 Q1 50,269,592 $1,621,969,076 +$127,818,413 $32.26 217
2024 Q4 46,483,344 $1,421,304,781 -$87,630,696 $30.56 209
2024 Q3 49,264,286 $1,381,109,066 -$12,223,311 $28.04 198
2024 Q2 50,723,505 $1,155,009,424 +$19,813,566 $22.77 194
2024 Q1 49,351,679 $1,501,026,424 +$67,021,576 $30.42 218
2023 Q4 47,164,039 $1,683,028,664 +$48,077,369 $35.69 230
2023 Q3 45,425,624 $1,988,207,852 +$14,251,801 $43.80 224
2023 Q2 45,005,948 $2,219,137,443 +$14,004,669 $49.36 219
2023 Q1 44,806,862 $1,857,210,760 -$5,467,106 $41.45 219
2022 Q4 44,912,321 $1,992,625,452 +$11,085,452 $44.38 207
2022 Q3 44,732,086 $1,747,349,909 -$40,042,063 $39.10 201
2022 Q2 44,464,969 $1,816,797,154 +$5,915,882 $40.86 196
2022 Q1 44,016,086 $2,889,958,812 -$4,881,515 $65.67 206
2021 Q4 44,091,364 $3,064,833,086 +$50,071,000 $69.53 211
2021 Q3 43,335,200 $3,014,938,884 -$67,863,474 $69.55 206
2021 Q2 44,284,173 $3,513,197,655 -$20,715,510 $79.33 206
2021 Q1 44,587,200 $2,919,424,135 +$101,599,138 $65.52 184
2020 Q4 44,006,691 $2,449,180,355 +$92,888,778 $55.67 191
2020 Q3 42,560,668 $1,698,181,209 +$16,788,166 $39.90 178
2020 Q2 41,949,121 $1,885,283,353 +$271,715,763 $44.95 184
2020 Q1 36,027,641 $1,210,074,214 +$38,131,339 $33.59 151
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .